The international, prospective CytOSorbⓇ treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patients
Ricard Ferrer(Vall d'Hebron Hospital Universitari), Fabio Silvio Taccone(Université Libre de Bruxelles), Bartosz Tyczynski(Essen University Hospital), Jorge Hidalgo(Central America Health Sciences University), Dietrich Henzler(Herford Hospital), Julian Kreutz(Philipps University of Marburg), Joerg Scheier(CytoSorbents (Germany)), Matthias Thielmann, Aschraf El‐Essawi, Andreas Baumann(BG University Hospital Bergmannsheil Bochum), Jean–Louis Teboul(Bicêtre Hospital), Andreas Kribben, Martin Bellgardt(St. Josef-Hospital), Efthymios Deliargyris(CytoSorbents (United States)), Dana Tomescu(Carol Davila University of Medicine and Pharmacy), Ulf Guenther(Klinikum Oldenburg), Teresa Klaus(CytoSorbents (Germany)), Thomas Kirschning(Heart and Diabetes Center North Rhine-Westphalia), Thomas Günther Pomorski(University of Copenhagen), Weihong Fan(CytoSorbents (United States)), Filippo Aucella(Casa Sollievo della Sofferenza), Moritz Unglaube(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Gabriella Bottari(Seattle Children's Hospital)
Cited by 8
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.7k
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
|European Heart Journal|2024|818